Related Experiment Video

Updated: Aug 6, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Is FAP the key to unlocking treatment for rare soft-tissue sarcomas?

Steven H Liang1,2

  • 1Department of Radiology and Imaging Sciences, Emory University Atlanta, Georgia 30322, United States.

American Journal of Nuclear Medicine and Molecular Imaging
|July 24, 2026
PubMed
Summary

Fibroblast activation protein (FAP) is a promising target for solitary fibrous tumors (SFTs). 90Y-FAPI-46 shows therapeutic potential in FAP-expressing SFTs, offering a new treatment option.

Keywords:
Fibroblast activation protein (FAP)radiolabeled FAPI tracersradiopharmaceutical therapysolitary fibrous tumors (SFTs)

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...